TRIER PHARM ApS: Financial statements 2020
CVR: 31611083
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -35,048 and a net result of DKK -56,020 compared with DKK -39,600 the year before. Equity in the 2020 report amounted to DKK -475,723.
- Gross Profit
- DKK -35,048
- Profit/Loss
- DKK -56,020
- Equity
- DKK -475,723
- Total Assets
- DKK 443,726
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -35 t. | -56 t. | -476 t. | - |
| 2019 | 528 t. | -24 t. | -40 t. | -420 t. | - |
| 2018 | 470 t. | -3 t. | -21 t. | -380 t. | - |
| 2017 | 481 t. | 20 t. | 2 t. | -359 t. | - |
| 2016 | 494 t. | 179 t. | -600 t. | -361 t. | - |
Official annual report
How creditworthy is TRIER PHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TRIER PHARM ApS has published its annual report for 2019. Revenue came to DKK 527,500, and the net result was DKK -39,600.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.